🚨 Pfizer Seeks FDA Approval for RSV Vaccine for Young Adults, Is Also Conducting RSV Trial for Kids as Young as 2 Four members of the FDA’s vaccine advisory committee voted against approving the drug because they said the safety data weren’t adequate given concerns regarding Guillain-Barré. Despite their concerns, the FDA approved the drug. ⬇️ <a target='_blank' rel='nofollow' href='https://childrenshealthdefense.org/defender/pfizer-fda-approval-rsv-vaccine-young-adults-trial-kids/?utm_source=sovren&utm_medium=social&utm_campaign=defender&utm_id=20240409'>https://childrenshealthdefense.org/defender/pfizer-fda-approval-rsv-vaccine-young-adults-trial-kids/?utm_source=sovren&utm_medium=social&utm_campaign=defender&utm_id=20240409</a>